An amendment correcting or updating a company's annual report.

NeXtGen Biologics, INC

NeXtGen Biologics, INC filed a Form C-AR/A — annual report (amended) — with the SEC on Apr 29, 2024.

The summary above is auto-extracted from the filing’s structured data on the SEC’s EDGAR system and shown for easy reading. Always confirm details against the official filing before acting. Inclusion here is not a recommendation or endorsement.